Scarica l'app Stockscreener
14.51
0.83%
0.12
Precedente Chiudi:
$14.39
Aprire:
$14.56
Volume 24 ore:
238.06K
Relative Volume:
0.84
Capitalizzazione di mercato:
$378.01M
Reddito:
$31.38M
Utile/perdita netta:
$-6.69M
Rapporto P/E:
-55.81
EPS:
-0.26
Flusso di cassa netto:
$-1.84M
1 W Prestazione:
-11.61%
1M Prestazione:
-4.98%
6M Prestazione:
+250.48%
1 anno Prestazione:
+226.07%
Intervallo 1D:
$14.30
$14.91
Intervallo di 1 settimana:
$14.18
$17.13
Portata 52W:
$3.03
$18.41
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Nome
Eton Pharmaceuticals Inc
Settore
Telefono
(847) 787-7361
Indirizzo
21925 W. FIELD PARKWAY, DEER PARK, IL
Confronta ETON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
14.51 | 378.01M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-23 | Reiterato | H.C. Wainwright | Buy |
| 2025-01-10 | Iniziato | B. Riley Securities | Buy |
| 2025-01-06 | Reiterato | H.C. Wainwright | Buy |
| 2024-09-04 | Ripresa | H.C. Wainwright | Buy |
| 2024-05-06 | Iniziato | Craig Hallum | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-01-04 | Reiterato | H.C. Wainwright | Buy |
| 2019-09-20 | Iniziato | B. Riley FBR | Buy |
| 2019-06-10 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Eton Pharmaceuticals Inc Borsa (ETON) Ultime notizie
Insider Buying: Opaleye Management Inc., Eton Pharmaceuticals Inc [ETON] 10% Owner invested 10,000 shares - Knox Daily
What Are You Thinking About Investing In Eton Pharmaceuticals Inc (NASDAQ: ETON) Stock? - Stocks Register
Here's Why Momentum in Eton Pharmaceuticals (ETON) Should Keep going - MSN
Learn to Evaluate (ETON) using the Charts - Stock Traders Daily
Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World
Eton Pharmaceuticals Stock Hits All-Time High of $17.57 - MSN
FDA extends target action date for Eton's ET-400 - MSN
Eton Pharmaceuticals Receives FDA Extension for NDA for ET-400On February 6, 2025, Eton Pharmaceuticals, Inc. announced through a press release that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUF - Defense World
Eton Pharmaceuticals receives new U.S. patent for ET-600 - MSN
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) 45% Jump Shows Its Popularity With Investors - Simply Wall St
Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation -February 07, 2025 at 07:09 am EST - Marketscreener.com
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 - The Manila Times
Major Patent Win: Eton's Game-Changing Liquid Diabetes Drug Gets 20-Year Protection - StockTitan
Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May -February 06, 2025 at 10:15 am EST - Marketscreener.com
Eton Pharmaceuticals : FDA Extends ET-400 Review to Late May -February 06, 2025 at 08:37 am EST - Marketscreener.com
Eton Pharmaceuticals: FDA Extends ET-400 Review to Late May - MarketWatch
Eton Pharmaceuticals: FDA extends PDUFA date for NDA for ET-400 to 5/28 - TipRanks
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire
Eton's Pediatric Rare Disease Drug Faces 3-Month FDA Review ExtensionRevenue Outlook Unchanged - StockTitan
Baader Bank Aktiengesellschaft Takes $373,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat
Eton Pharmaceuticals Stock Hits All-Time High of $17.57 By Investing.com - Investing.com Nigeria
New Strong Buy Stocks for January 28th - Yahoo Finance
Here's What Could Help Eton Pharmaceuticals (ETON) Maintain Its Recent Price Strength - Yahoo Finance
Biotech Stocks Facing FDA Decision In February 2025 - RTTNews
Q2 EPS Estimate for Eton Pharmaceuticals Lifted by Analyst - MarketBeat
Q2 EPS Estimate for Eton Pharmaceuticals Raised by Analyst - Defense World
Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum - Yahoo Finance
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? - MSN
HC Wainwright Has Negative Outlook for ETON Q1 Earnings - Defense World
Q1 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst - MarketBeat
Westside Investment Management Inc. Sells 43,453 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat
HC Wainwright Issues Positive Forecast for Eton Pharmaceuticals (NASDAQ:ETON) Stock Price - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even - Simply Wall St
Eton Pharmaceuticals stock soars to all-time high of $15.11 - MSN
Eton Pharmaceuticals stock soars to all-time high of $15.11 By Investing.com - Investing.com Australia
Eton acquires Wilson disease drug Galzin - MSN
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
15,006 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by Jane Street Group LLC - Defense World
Q1 Earnings Estimate for ETON Issued By B. Riley - Defense World
Q1 Earnings Forecast for ETON Issued By B. Riley - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Coverage Initiated at B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at B. Riley - Defense World
Eton Pharmaceuticals Inc Azioni (ETON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Eton Pharmaceuticals Inc Azioni (ETON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Oct 23 '24 |
Buy |
7.98 |
10,000 |
79,814 |
2,770,000 |
| Opaleye Management Inc. | 10% Owner |
Oct 08 '24 |
Buy |
7.03 |
33,970 |
238,782 |
2,760,000 |
| Opaleye Management Inc. | 10% Owner |
Oct 04 '24 |
Buy |
6.77 |
16,852 |
114,105 |
2,720,000 |
| Opaleye Management Inc. | 10% Owner |
Oct 07 '24 |
Buy |
7.22 |
11,248 |
81,250 |
2,730,000 |
| Opaleye Management Inc. | 10% Owner |
Sep 10 '24 |
Buy |
4.65 |
57,500 |
267,375 |
2,660,000 |
| Opaleye Management Inc. | 10% Owner |
Sep 11 '24 |
Buy |
4.75 |
50,000 |
237,500 |
2,705,000 |
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):